This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Jump to section
Related Articles
Cited By...
- Comparison of 11C-Methionine and 18F-FDG PET/CT for Staging and Follow-up of Pediatric Lymphoma
- Usefulness of 18F-{alpha}-Methyltyrosine PET for Therapeutic Monitoring of Patients with Advanced Lung Cancer
- FDG PET-CT in follicular lymphoma: a case-based evidence review
- Tumor Cell Metabolism Imaging
- The Role of PET in Lymphoma
- Intensity of 18Fluorodeoxyglucose Uptake in Positron Emission Tomography Distinguishes Between Indolent and Aggressive Non-Hodgkin's Lymphoma
- Role of Positron Emission Tomography in Lymphoma
- Utility of FDG-PET scanning in lymphoma by WHO classification
- Combined 18F-FDG and 11C-Methionine PET Scans in Patients with Newly Progressive Metastatic Prostate Cancer
- Whole-Body Hybrid PET with 18F-FDG in the Staging of Non-Hodgkin's Lymphoma
- Radiolabeled Amino Acids: Basic Aspects and Clinical Applications in Oncology
- Nodal Staging of Lymphoma with Whole-Body PET: Comparison of [11C]Methionine and FDG
- Positron Emission Tomography in Non-Hodgkin's Lymphoma: Assessment of Chemotherapy With Fluorodeoxyglucose